Login / Signup

Drug survival for biologics in psoriasis patients: real world evidence for Greece during the period 2016-2020.

Elizabeth LazaridouGeorgia KourlabaStylianos RavanidisGeorge GounelasGaryfallia StefanouAnastasios TsolakidisKonstantinos MathioudakisZoe Apalla
Published in: Clinical and experimental dermatology (2024)
Our findings confirm previous reports regarding the importance of efficient 1st line biologics and the vulnerability of patients to co-existent PsA. The utilitzation of antibodies against interleukins confer to high drug survival rates. These results will assist clinical management of psoriasis patients in Greece.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • emergency department
  • climate change
  • free survival